A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aurore Perrot, M.D.
Universite de Toulouse
Principal Investigator - Martin Kaiser, M.D.
The Royal Marsden
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Honorhealth
Scottsdale, Arizona, United States
Recruiting - Berenson Cancer Center
West Hollywood, California, United States
Recruiting - Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
Recruiting - Indiana University Health
Indianapolis, Indiana, United States
Recruiting - Start Midwest
Grand Rapids, Michigan, United States
Recruiting - Washington University/siteman Cancer Center
St Louis, Missouri, United States
Recruiting - University of Nebraska Medical Center
Omaha, Nebraska, United States
Recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Start San Antonio
San Antonio, Texas, United States
Recruiting - University of Wisconsin - Carbone Cancer Center
Madison, Wisconsin, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Feb 2026
- Primary completion
- 31 Mar 2030
- Completion
- 31 Mar 2030
- Last update posted
- 1 Jul 2026
- Registered enrollment
- 100
- Registry id
- NCT07284758
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.